FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000346583> ?p ?o ?g. }

• W2000346583 endingPage "436" @default.
• W2000346583 startingPage "429" @default.
• W2000346583 abstract "In this short review we have tried to focus on some new relevant aspects of the pharmacological control of inflammation. The clinical availability of new drugs able to produce a selective inhibition of type 2 cyclooxygenase (COX-2), the enzyme thought to be mainly responsible for generating arachidonic-acid-derived inflammatory mediators, has been the origin of much hope. However, expectations of having an effective and completely safe non-steroidal anti-inflammatory drug (NSAID) have been only partially fulfilled. Emerging information has challenged some aspects of the original hypothesis indicating COX-2 as devoid of 'housekeeping' physiological functions. Moreover, the recently available clinical studies have indicated only a relatively small improvement in the tolerability of the newer 'selective' COX-2 inhibitors over the classical COX-1/COX-2 mixed type NSAIDs. The new appreciation of the role of other arachidonic acid derivatives, the leukotrienes (LTS), in producing and maintaining inflammation has generated considerable interest in drugs able to block LTS receptors or to produce a selective inhibition of 5-lipoxygenase (5-LO), the initial key enzyme of the leukotriene pathway. These drugs are now included among the effective therapies of asthma but appear, in the few clinical studies performed, to be an insufficient single therapeutic approach in other inflammatory diseases. Drugs able to block equally well both COX and 5-LO metabolic pathways (dual inhibitors) have been developed and experimentally evaluated in the last few years, but none are available on the market yet. The pharmacological rationale at the basis of their development is strong, and animal studies are indicative of a wide range of anti-inflammatory activity. What appears most impressive from the available studies on dual inhibitors is their almost complete lack of gastric toxicity, the most troublesome side effect of NSAIDs. The mechanism of the gastric-sparing properties of these drugs is not yet completely understood; however, it appears that leukotrienes significantly contribute to gastric epithelial injury particularly when these compounds represent the major arachidonic acid derivatives present in the gastric mucosa after inhibiton of prostanoid production." @default.
• W2000346583 created "2016-06-24" @default.
• W2000346583 creator A5031324853 @default.
• W2000346583 creator A5070271118 @default.
• W2000346583 date "2001-05-01" @default.
• W2000346583 modified "2023-10-11" @default.
• W2000346583 title "Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept" @default.
• W2000346583 cites W1536616493 @default.
• W2000346583 cites W1672565987 @default.
• W2000346583 cites W1674826207 @default.
• W2000346583 cites W1966044567 @default.
• W2000346583 cites W1968219794 @default.
• W2000346583 cites W1969466652 @default.
• W2000346583 cites W1974460113 @default.
• W2000346583 cites W1979317400 @default.
• W2000346583 cites W1980709890 @default.
• W2000346583 cites W1980832959 @default.
• W2000346583 cites W1985844039 @default.
• W2000346583 cites W1986512651 @default.
• W2000346583 cites W1987709173 @default.
• W2000346583 cites W1993425629 @default.
• W2000346583 cites W1994378803 @default.
• W2000346583 cites W1994862373 @default.
• W2000346583 cites W2000545225 @default.
• W2000346583 cites W2000891017 @default.
• W2000346583 cites W2001214229 @default.
• W2000346583 cites W2005807165 @default.
• W2000346583 cites W2006512496 @default.
• W2000346583 cites W2007567412 @default.
• W2000346583 cites W2010673118 @default.
• W2000346583 cites W2011990718 @default.
• W2000346583 cites W2013166307 @default.
• W2000346583 cites W2014768234 @default.
• W2000346583 cites W2017917394 @default.
• W2000346583 cites W2018630281 @default.
• W2000346583 cites W2018714950 @default.
• W2000346583 cites W2019422381 @default.
• W2000346583 cites W2026091403 @default.
• W2000346583 cites W2029251290 @default.
• W2000346583 cites W2040040765 @default.
• W2000346583 cites W2040526845 @default.
• W2000346583 cites W2040595591 @default.
• W2000346583 cites W2041247450 @default.
• W2000346583 cites W2041359157 @default.
• W2000346583 cites W2042274378 @default.
• W2000346583 cites W2043008520 @default.
• W2000346583 cites W2044750065 @default.
• W2000346583 cites W2048423840 @default.
• W2000346583 cites W2053312234 @default.
• W2000346583 cites W2054044627 @default.
• W2000346583 cites W2055566413 @default.
• W2000346583 cites W2055909907 @default.
• W2000346583 cites W2064951559 @default.
• W2000346583 cites W2065305152 @default.
• W2000346583 cites W2068411193 @default.
• W2000346583 cites W2072359526 @default.
• W2000346583 cites W2076510126 @default.
• W2000346583 cites W2077814747 @default.
• W2000346583 cites W2082906650 @default.
• W2000346583 cites W2083651943 @default.
• W2000346583 cites W2084256772 @default.
• W2000346583 cites W2087019177 @default.
• W2000346583 cites W2091639856 @default.
• W2000346583 cites W2092193486 @default.
• W2000346583 cites W2092927862 @default.
• W2000346583 cites W2093976871 @default.
• W2000346583 cites W2095942707 @default.
• W2000346583 cites W2098792606 @default.
• W2000346583 cites W2099544734 @default.
• W2000346583 cites W2101492631 @default.
• W2000346583 cites W2107864895 @default.
• W2000346583 cites W2111386662 @default.
• W2000346583 cites W2114014099 @default.
• W2000346583 cites W2115679325 @default.
• W2000346583 cites W2120102288 @default.
• W2000346583 cites W2123151902 @default.
• W2000346583 cites W2124678826 @default.
• W2000346583 cites W2125731088 @default.
• W2000346583 cites W2127558096 @default.
• W2000346583 cites W2146625461 @default.
• W2000346583 cites W2146839586 @default.
• W2000346583 cites W2151426228 @default.
• W2000346583 cites W2166525518 @default.
• W2000346583 cites W2327878210 @default.
• W2000346583 cites W2341080885 @default.
• W2000346583 cites W2397068357 @default.
• W2000346583 doi "https://doi.org/10.1006/phrs.2000.0784" @default.
• W2000346583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11394934" @default.
• W2000346583 hasPublicationYear "2001" @default.
• W2000346583 type Work @default.
• W2000346583 sameAs 2000346583 @default.
• W2000346583 citedByCount "147" @default.
• W2000346583 countsByYear W20003465832012 @default.
• W2000346583 countsByYear W20003465832013 @default.
• W2000346583 countsByYear W20003465832014 @default.
• W2000346583 countsByYear W20003465832015 @default.
• W2000346583 countsByYear W20003465832016 @default.
• W2000346583 countsByYear W20003465832017 @default.

• next